Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.06
SNN's Cash to Debt is ranked lower than
96% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 2.27 vs. SNN: 0.06 )
SNN' s 10-Year Cash to Debt Range
Min: 0.06   Max: 2.58
Current: 0.06

0.06
2.58
Equity to Asset 0.55
SNN's Equity to Asset is ranked lower than
62% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. SNN: 0.55 )
SNN' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.7
Current: 0.55

0.34
0.7
Interest Coverage 21.40
SNN's Interest Coverage is ranked lower than
74% of the 161 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. SNN: 21.40 )
SNN' s 10-Year Interest Coverage Range
Min: 7.79   Max: 94
Current: 21.4

7.79
94
F-Score: 6
Z-Score: 4.94
M-Score: -2.65
WACC vs ROIC
7.00%
10.03%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 16.26
SNN's Operating margin (%) is ranked higher than
84% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.51 vs. SNN: 16.26 )
SNN' s 10-Year Operating margin (%) Range
Min: 12.6   Max: 23.22
Current: 16.26

12.6
23.22
Net-margin (%) 10.89
SNN's Net-margin (%) is ranked higher than
81% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. SNN: 10.89 )
SNN' s 10-Year Net-margin (%) Range
Min: 8.9   Max: 26.81
Current: 10.89

8.9
26.81
ROE (%) 12.30
SNN's ROE (%) is ranked higher than
77% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 3.24 vs. SNN: 12.30 )
SNN' s 10-Year ROE (%) Range
Min: 12.67   Max: 47.17
Current: 12.3

12.67
47.17
ROA (%) 7.30
SNN's ROA (%) is ranked higher than
76% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: -0.11 vs. SNN: 7.30 )
SNN' s 10-Year ROA (%) Range
Min: 7.79   Max: 22.64
Current: 7.3

7.79
22.64
ROC (Joel Greenblatt) (%) 36.22
SNN's ROC (Joel Greenblatt) (%) is ranked higher than
83% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 3.35 vs. SNN: 36.22 )
SNN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 29.57   Max: 70.26
Current: 36.22

29.57
70.26
Revenue Growth (3Y)(%) 2.50
SNN's Revenue Growth (3Y)(%) is ranked lower than
55% of the 185 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. SNN: 2.50 )
SNN' s 10-Year Revenue Growth (3Y)(%) Range
Min: 1   Max: 37.2
Current: 2.5

1
37.2
EBITDA Growth (3Y)(%) 0.40
SNN's EBITDA Growth (3Y)(%) is ranked lower than
51% of the 155 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. SNN: 0.40 )
SNN' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -2.4   Max: 36.3
Current: 0.4

-2.4
36.3
EPS Growth (3Y)(%) -4.90
SNN's EPS Growth (3Y)(%) is ranked higher than
50% of the 160 Companies
in the Global Medical Devices industry.

( Industry Median: -4.90 vs. SNN: -4.90 )
SNN' s 10-Year EPS Growth (3Y)(%) Range
Min: -8.2   Max: 57.4
Current: -4.9

-8.2
57.4
» SNN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

SNN Guru Trades in Q2 2014

Louis Moore Bacon 30,000 sh (New)
Mario Gabelli 9,650 sh (New)
Jim Simons 143,000 sh (+69.83%)
Ken Fisher 1,361,425 sh (+36.95%)
Steven Cohen 204,800 sh (unchged)
John Hussman 19,500 sh (unchged)
David Dreman 74,877 sh (-4.15%)
Pioneer Investments 33,902 sh (-11.72%)
» More
Q3 2014

SNN Guru Trades in Q3 2014

Mario Gabelli 15,350 sh (+59.07%)
Louis Moore Bacon 40,000 sh (+33.33%)
Jim Simons 171,800 sh (+20.14%)
John Hussman 19,500 sh (unchged)
Pioneer Investments 34,059 sh (unchged)
Steven Cohen Sold Out
David Dreman 74,325 sh (-0.74%)
Ken Fisher 973,153 sh (-28.52%)
» More
Q4 2014

SNN Guru Trades in Q4 2014

Pioneer Investments 84,570 sh (+148.30%)
John Hussman 48,750 sh (unchged)
Louis Moore Bacon Sold Out
Ken Fisher 2,291,837 sh (-5.80%)
Mario Gabelli 31,875 sh (-16.94%)
David Dreman 148,777 sh (-19.93%)
Jim Simons 343,850 sh (-19.94%)
» More
Q1 2015

SNN Guru Trades in Q1 2015

Eric Mindich 502,000 sh (New)
Ken Fisher 2,299,852 sh (+0.35%)
Pioneer Investments 84,570 sh (unchged)
Jim Simons 310,000 sh (-9.84%)
Mario Gabelli 25,875 sh (-18.82%)
David Dreman 117,479 sh (-21.04%)
John Hussman 15,000 sh (-69.23%)
» More
» Details

Insider Trades

Latest Guru Trades with SNN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 33.50
SNN's P/E(ttm) is ranked lower than
71% of the 151 Companies
in the Global Medical Devices industry.

( Industry Median: 25.30 vs. SNN: 33.50 )
Ranked among companies with meaningful P/E(ttm) only.
SNN' s 10-Year P/E(ttm) Range
Min: 10.22   Max: 44.27
Current: 33.5

10.22
44.27
Forward P/E 30.03
SNN's Forward P/E is ranked higher than
81% of the 105 Companies
in the Global Medical Devices industry.

( Industry Median: 22.03 vs. SNN: 30.03 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 33.00
SNN's PE(NRI) is ranked lower than
57% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 28.80 vs. SNN: 33.00 )
Ranked among companies with meaningful PE(NRI) only.
SNN' s 10-Year PE(NRI) Range
Min: 11.42   Max: 45.28
Current: 33

11.42
45.28
P/B 3.90
SNN's P/B is ranked lower than
81% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. SNN: 3.90 )
Ranked among companies with meaningful P/B only.
SNN' s 10-Year P/B Range
Min: 0.55   Max: 8.19
Current: 3.9

0.55
8.19
P/S 3.40
SNN's P/S is ranked lower than
73% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 2.18 vs. SNN: 3.40 )
Ranked among companies with meaningful P/S only.
SNN' s 10-Year P/S Range
Min: 1.67   Max: 4.76
Current: 3.4

1.67
4.76
PFCF 52.10
SNN's PFCF is ranked lower than
110% of the 114 Companies
in the Global Medical Devices industry.

( Industry Median: 25.50 vs. SNN: 52.10 )
Ranked among companies with meaningful PFCF only.
SNN' s 10-Year PFCF Range
Min: 12.57   Max: 190.33
Current: 52.1

12.57
190.33
POCF 24.13
SNN's POCF is ranked lower than
59% of the 153 Companies
in the Global Medical Devices industry.

( Industry Median: 20.43 vs. SNN: 24.13 )
Ranked among companies with meaningful POCF only.
SNN' s 10-Year POCF Range
Min: 8.22   Max: 38.07
Current: 24.13

8.22
38.07
EV-to-EBIT 25.70
SNN's EV-to-EBIT is ranked lower than
56% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 22.45 vs. SNN: 25.70 )
Ranked among companies with meaningful EV-to-EBIT only.
SNN' s 10-Year EV-to-EBIT Range
Min: 8.8   Max: 51.5
Current: 25.7

8.8
51.5
PEG 13.20
SNN's PEG is ranked lower than
89% of the 53 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. SNN: 13.20 )
Ranked among companies with meaningful PEG only.
SNN' s 10-Year PEG Range
Min: 0.3   Max: 33.76
Current: 13.2

0.3
33.76
Shiller P/E 27.00
SNN's Shiller P/E is ranked lower than
56% of the 93 Companies
in the Global Medical Devices industry.

( Industry Median: 24.60 vs. SNN: 27.00 )
Ranked among companies with meaningful Shiller P/E only.
SNN' s 10-Year Shiller P/E Range
Min: 15.69   Max: 33.82
Current: 27

15.69
33.82
Current Ratio 2.10
SNN's Current Ratio is ranked lower than
59% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 2.48 vs. SNN: 2.10 )
Ranked among companies with meaningful Current Ratio only.
SNN' s 10-Year Current Ratio Range
Min: 0.84   Max: 2.42
Current: 2.1

0.84
2.42
Quick Ratio 1.08
SNN's Quick Ratio is ranked lower than
76% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. SNN: 1.08 )
Ranked among companies with meaningful Quick Ratio only.
SNN' s 10-Year Quick Ratio Range
Min: 0.47   Max: 1.35
Current: 1.08

0.47
1.35
Days Inventory 354.48
SNN's Days Inventory is ranked lower than
91% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 130.93 vs. SNN: 354.48 )
Ranked among companies with meaningful Days Inventory only.
SNN' s 10-Year Days Inventory Range
Min: 211.9   Max: 336.53
Current: 354.48

211.9
336.53
Days Sales Outstanding 79.87
SNN's Days Sales Outstanding is ranked lower than
60% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 67.63 vs. SNN: 79.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
SNN' s 10-Year Days Sales Outstanding Range
Min: 73.2   Max: 97.4
Current: 79.87

73.2
97.4

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.60
SNN's Dividend Yield is ranked higher than
66% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 2.60 )
Ranked among companies with meaningful Dividend Yield only.
SNN' s 10-Year Dividend Yield Range
Min: 0.56   Max: 2.27
Current: 2.6

0.56
2.27
Dividend Payout 0.78
SNN's Dividend Payout is ranked higher than
52% of the 95 Companies
in the Global Medical Devices industry.

( Industry Median: 0.31 vs. SNN: 0.78 )
Ranked among companies with meaningful Dividend Payout only.
SNN' s 10-Year Dividend Payout Range
Min: 0.13   Max: 4.43
Current: 0.78

0.13
4.43
Dividend growth (3y) 14.30
SNN's Dividend growth (3y) is ranked higher than
72% of the 46 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. SNN: 14.30 )
Ranked among companies with meaningful Dividend growth (3y) only.
SNN' s 10-Year Dividend growth (3y) Range
Min: -54   Max: 19.6
Current: 14.3

-54
19.6
Yield on cost (5-Year) 5.65
SNN's Yield on cost (5-Year) is ranked higher than
87% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 5.65 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
SNN' s 10-Year Yield on cost (5-Year) Range
Min: 1.22   Max: 4.93
Current: 5.65

1.22
4.93
Share Buyback Rate 0.10
SNN's Share Buyback Rate is ranked higher than
78% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: -2.80 vs. SNN: 0.10 )
Ranked among companies with meaningful Share Buyback Rate only.
SNN' s 10-Year Share Buyback Rate Range
Min: 23.3   Max: -0.6
Current: 0.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 62.60
SNN's Price/Tangible Book is ranked lower than
155% of the 249 Companies
in the Global Medical Devices industry.

( Industry Median: 3.10 vs. SNN: 62.60 )
Ranked among companies with meaningful Price/Tangible Book only.
SNN' s 10-Year Price/Tangible Book Range
Min: 4.14   Max: 166.63
Current: 62.6

4.14
166.63
Price/DCF (Projected) 2.10
SNN's Price/DCF (Projected) is ranked lower than
66% of the 114 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. SNN: 2.10 )
Ranked among companies with meaningful Price/DCF (Projected) only.
SNN' s 10-Year Price/DCF (Projected) Range
Min: 1.04   Max: 3.27
Current: 2.1

1.04
3.27
Price/Median PS Value 1.30
SNN's Price/Median PS Value is ranked lower than
75% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 1.00 vs. SNN: 1.30 )
Ranked among companies with meaningful Price/Median PS Value only.
SNN' s 10-Year Price/Median PS Value Range
Min: 0.66   Max: 1.83
Current: 1.3

0.66
1.83
Price/Graham Number 9.60
SNN's Price/Graham Number is ranked lower than
124% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 2.50 vs. SNN: 9.60 )
Ranked among companies with meaningful Price/Graham Number only.
SNN' s 10-Year Price/Graham Number Range
Min: 0.93   Max: 10
Current: 9.6

0.93
10
Earnings Yield (Greenblatt) 3.90
SNN's Earnings Yield (Greenblatt) is ranked higher than
70% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. SNN: 3.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
SNN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.9   Max: 11.4
Current: 3.9

1.9
11.4
Forward Rate of Return (Yacktman) 2.95
SNN's Forward Rate of Return (Yacktman) is ranked lower than
51% of the 100 Companies
in the Global Medical Devices industry.

( Industry Median: 3.09 vs. SNN: 2.95 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) only.
SNN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 1.7   Max: 72.5
Current: 2.95

1.7
72.5

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:SN..UK, NPW1.Germany, NPWA.Germany, SNNUF.USA,
Smith & Nephew PLC was incorporated on February 17, 1937. The Company develops, manufactures, markets and sells medical devices. The Company is organized into business segments namely Advanced Surgical Devices and Advanced Wound Management. The Advanced Surgical Devices offers Orthopaedic Reconstruction which includes Hip Implants, Knee Implants and ancillary products such as bone cement and mixing systems used in cemented reconstruction joint surgery, Trauma & Extremities consisting of internal and external devices used in the stabilisation of severe fractures and deformity correction procedures, Sports Medicine Joint Repair, which offers surgeons a various instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, Arthroscopy Enabling Technologies which offer healthcare providers various technologies such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources and monitors to assist with visualisation inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. The Advanced Wound Management segment offers Advanced Wound Care includes products for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns and post-operative wounds, Advanced Wound Devices consists of traditional and single-use Negative Pressure Wound Therapy and hydrosurgery systems, Advanced Wound Bioactives includes biologics and other bioactive technologies that provide approaches to debridement and dermal repair/regeneration. The Company operates across the world and is subject to legislation, including anti-bribery and corruption and data protection, in each country in which it operates.
» More Articles for SNN

Headlines

Articles On GuruFocus.com
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
Sintana Energy Reports on Execution of Drilling Rig Contract Dec 11 2014 
3 Dividend Kings From The U.K. I Love To Buy Aug 21 2014 
Stryker Corporation (SYK) Dividend Stock Analysis Jan 11 2013 
5 Highly Predictable Mid-/Large-Caps with ROC Over 15% Apr 21 2012 
The Best Dividends on April 18, 2012 Apr 18 2012 
5 Healthcare Stocks to Consider Today Mar 21 2012 
medical Feb 29 2012 
Stryker Corp. (SYK) Dividend Stock Analysis Dec 16 2011 
comment on SNN Nov 08 2011 

More From Other Websites
Should You Buy Neil Woodford Rejects HSBC Holdings plc, Reckitt Benckiser Group Plc And Smith &... May 27 2015
BSN Medical Luxembourg S.a.r.l. -- Moody's affirms B2 CFR to BSN Medical Luxembourg Group Holding... May 20 2015
OrthoSpace Completes Significant Financing May 19 2015
Coverage initiated on Smith & Nephew by Northland Capital May 14 2015
Smith & Nephew acquires interactive software technology to drive supply chain optimisation and... May 06 2015
Smith & Nephew acquires interactive software technology to drive supply chain optimisation and... May 06 2015
New Study Shows Diabetic Foot Ulcers Treated with OASIS® Ultra Tri-Layer Matrix Demonstrated... May 01 2015
3 FTSE 100 Stocks Set To Soar: SSE PLC, Smith & Nephew plc And Burberry Group plc Apr 30 2015
New Study Shows Diabetic Foot Ulcers Treated with OASIS® Ultra Tri-Layer Matrix Demonstrated... Apr 30 2015
Smith & Nephew posts three percent higher first-quarter revenue Apr 30 2015
Smith & Nephew 2015 First Quarter Trading Report Apr 30 2015
Smith & Nephew posts 3 pct higher first-quarter revenue Apr 30 2015
Smith & Nephew Advanced Wound Management Expands Presence at the Symposium on Advanced Wound Care Apr 29 2015
India Joint Replacement Market to Grow in Double Digits Through 2020 Apr 27 2015
Smith & Nephew Advanced Wound Management Supports Wound Care Nurses Apr 13 2015
Smith & Nephew Advanced Wound Management Supports Wound Care Nurses Apr 13 2015
AstraZeneca plc vs Smith & Nephew plc vs Indivior PLC: Which Healthcare Stock Should You Buy? Apr 09 2015
Southwest scores federal funding for training facility Apr 07 2015
Growing body of evidence supports use of PICO◊ Negative Pressure Wound Therapy to address... Mar 31 2015
Growing body of evidence supports use of PICO◊ Negative Pressure Wound Therapy to address... Mar 31 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK